Non-psychoactive cannabinoids modulate the descending pathway of antinociception in anaesthetized rats through several mechanisms of action

British Journal of Pharmacology

Volumn 162, Issue 3, 2011, Pages 584-596

  Maione, Sabatino ^a   Piscitelli, Fabiana ^b   Gatta, Luisa ^a   Vita, Daniela ^a   De Petrocellis, Luciano ^b   Palazzo, Enza ^a   De Novellis, Vito ^a   Di Marzo, Vincenzo ^b  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

^b CNR   (Italy)

Author keywords

adenosine; brainstem; cannabinoids; endocannabinoids; pain; receptors; serotonin; transporters; TRP channels

Indexed keywords

1 (2,4 DICHLOROPHENYL) 5 (4 IODOPHENYL) 4 METHYL N (1 PIPERIDYL) 1H PYRAZOLE 3 CARBOXAMIDE; 8 CYCLOPENTYL 1,3 DIPROPYLXANTHINE; ADENOSINE A1 RECEPTOR; CANNABICHROMENE; CANNABIDIOL; CANNABINOID; CANNABINOID 1 RECEPTOR; ENDOCANNABINOID; RESINIFERATOXIN; TRANSIENT RECEPTOR POTENTIAL CHANNEL A1; VANILLOID RECEPTOR 1;

ANALGESIA; ANESTHESIA INDUCTION; ANIMAL EXPERIMENT; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; DRUG STRUCTURE; MALE; NERVE CELL; NOCICEPTION; NONHUMAN; PERIAQUEDUCTAL GRAY MATTER; PRIORITY JOURNAL; RAT; TAIL FLICK TEST; THERMAL STIMULATION;

ANALGESICS; ANESTHESIA; ANIMALS; CANNABIDIOL; CANNABINOIDS; ENDOCANNABINOIDS; MALE; MEDULLA OBLONGATA; MICROINJECTIONS; NOCICEPTORS; PAIN MEASUREMENT; PERIAQUEDUCTAL GRAY; RATS; RATS, WISTAR; RECEPTOR, CANNABINOID, CB1; SIGNAL TRANSDUCTION; TAIL; TRANSIENT RECEPTOR POTENTIAL CHANNELS; TRPV CATION CHANNELS;

EID: 78651436142     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/j.1476-5381.2010.01063.x     Document Type: Article

References (73)

1. Akopian AN, Ruparel NB, Jeske NA, Hargreaves KM, (2007). Transient receptor potential TRPA1 channel desensitization in sensory neurons is agonist dependent and regulated by TRPV1-directed internalization. J Physiol 583: 175-193.
2. Akopian AN, Ruparel NB, Patwardhan A, Hargreaves KM, (2008). Cannabinoids desensitize capsaicin and mustard oil responses in sensory neurons via TRPA1 activation. J Neurosci 28: 1064-1075.
3. Alexander SPH, Mathie A, Peters JA, (2009). Guide to Receptors and Channels (GRAC), 4th edn. Br J Pharmacol 158 (Suppl. 1): S1-S254.
4. Basbaum AI, Fields HL, (1984). Endogenous pain control systems: brainstem spinal pathways and endorphin circuitry. Annu Rev Neurosci 7: 309-338.
5. Bederson JB, Fields HL, Barbaro NM, (1990). Hyperalgesia during naloxone-precipitated withdrawal from morphine is correlated with increased ON cell activity in the rostral ventromedial medulla. Somatosens Mot Res 7: 185-203.
6. Bee LA, Dickenson AH, (2007). Rostral ventromedial medulla control of spinal sensory processing in normal and pathophysiological states. Neuroscience 147: 786-793.
7. Behbehani MM, (1995). Functional characteristics of the midbrain periaqueductal gray. Prog Neurobiol 46: 575-605.
8. Behbehani MM, Fields HL, (1979). Evidence that an excitatory connection between the periaqueductal gray and nucleus raphe magnus mediates stimulation produced analgesia. Brain Res 170: 85-93.
9. Behbehani MM, Liu H, Jiang M, Pun RY, Shipley MT, (1993). Activation of serotonin1A receptors inhibits midbrain periaqueductal gray neurons of the rat. Brain Res 612: 56-60.
10. Bisogno T, Maurelli S, Melck D, De Petrocellis L, Di Marzo V, (1997). Biosynthesis, uptake, and degradation of anandamide and palmitoylethanolamide in leukocytes. J Biol Chem 272: 3315-3323.
11. Bisogno T, Hanus L, De Petrocellis L, Tchilibon S, Ponde DE, Brandi I, et al. (2001). Molecular targets for cannabidiol and its synthetic analogues: effect on vanilloid VR1 receptors and on the cellular uptake and enzymatic hydrolysis of anandamide. Br J Pharmacol 134: 845-852.
12. Bisogno T, De Petrocellis L, Di Marzo V, (2002). Fatty acid amide hydrolase, an enzyme with many bioactive substrates. Possible therapeutic implications. Curr Pharm Des 8: 533-547.
13. Cai X, (2008). A new tr(i)p to sense pain: TRPA1 channel as a target for novel analgesics. Expert Rev Neurother 8: 1675-1681.
14. Campos AC, Guimarães FS, (2008). Involvement of 5HT1A receptors in the anxiolytic-like effects of cannabidiol injected into the dorsolateral periaqueductal gray of rats. Psychopharmacology (Berl) 199: 223-230.
15. Carrier EJ, Auchampach JA, Hillard CJ, (2006). Inhibition of an equilibrative nucleoside transporter by cannabidiol: a mechanism of cannabinoid immunosuppression. Proc Natl Acad Sci U S A 103: 7895-7900.
16. Castillo A, Tolón MR, Fernández-Ruiz J, Romero J, Martinez-Orgado J, (2010). The neuroprotective effect of cannabidiol in an in vitro model of newborn hypoxic-ischemic brain damage in mice is mediated by CB(2) and adenosine receptors. Neurobiol Dis 37: 434-440.
17. De Petrocellis L, Vellani V, Schiano-Moriello A, Marini P, Magherini PC, Orlando P, et al. (2008). Plant-derived cannabinoids modulate the activity of transient receptor potential channels of ankyrin type-1 and melastatin type-8. J Pharmacol Exp Ther 325: 1007-1015.
18. Devane WA, Hanus L, Breuer A, Pertwee RG, Stevenson LA, Griffin G, et al. (1992). Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science 258: 1946-1949.
19. Fields HL, (2000). Pain modulation: expectation, opioid analgesia and virtual pain. Prog Brain Res 122: 245-253.
20. Fields HL, (2004). State-dependent opioid control of pain. Nat Rev Neurosci 5: 565-575.
21. Fields HL, Vanegas H, Hentall ID, Zorman G, (1983). Evidence that disinhibition of brain stem neurones contributes to morphine analgesia. Nature 306: 684-686.
22. Fields HL, Heinricher MM, Mason P, (1991). Neurotransmitters in nociceptive modulatory circuits. Annu Rev Neurosci 14: 219-245.
23. Fields HL, Malick A, Burstein R, (1995). Dorsal horn projection targets of ON and OFF cells in the rostral ventromedial medulla. J Neurophysiol 74: 1742-1759.
24. Foo H, Mason P, (2005). Sensory suppression during feeding. Proc Natl Acad Sci U S A 102: 16865-16869.
25. Harris RM, Hendrickson AE, (1987). Local circuit neurons in the rat ventrobasal thalamus-a GABA immunocytochemical study. Neuroscience 21: 229-236.
26. Heinricher MM, Ingram SL, (2008). The brainstem and nociceptive modulation. In:, Bushnell MC, Basbaum AI, (eds). The Senses, A Comprehensive Reference. Pain, Vol. 5. Academic Press: San Diego, CA, pp. 593-626.
27. Heinricher MM, McGaraughty S, (1998). Analysis of excitatory amino acid transmission within the rostral ventromedial medulla: implications for circuitry. Pain 75: 247-255.
28. Heinricher MM, Neubert MJ, (2004). Neural basis for the hyperalgesic action of cholecystokinin in the rostral ventromedial medulla. J Neurophysiol 92: 1982-1989.
29. Heinricher MM, Tortorici V, (1994). Interference with GABA transmission in the rostral ventromedial medulla: disinhibition of off-cells as a central mechanism in nociceptive modulation. Neuroscience 63: 533-546.
30. Heinricher MM, Barbaro NM, Fields HL, (1989). Putative nociceptive modulating neurons in the rostral ventromedial medulla of the rat: firing of ON and OFF cells is related to nociceptive responsiveness. Somatosens Mot Res 6: 427-439.
31. Heinricher MM, Tavares I, Leith JL, Lumb BM, (2009). Descending control of nociception: specificity, recruitment and plasticity. Brain Res Rev 60: 214-225.
32. Hoffman AF, Laaris N, Kawamura M, Masino SA, Lupica CR, (2010). Control of cannabinoid CB1 receptor function on glutamate axon terminals by endogenous adenosine acting at A1 receptors. J Neurosci 30: 545-555.
33. Huo FQ, Qu CL, Li YQ, Tang JS, Jia H, (2008). GABAergic modulation is involved in the ventrolateral orbital cortex 5-HT 1A receptor activation-induced antinociception in the rat. Pain 139: 398-405.
34. Jeske NA, Patwardhan AM, Gamper N, Price TJ, Akopian AN, Hargreaves KM, (2006). Cannabinoid WIN 55,212-2 regulates TRPV1 phosphorylation in sensory neurons. J Biol Chem 281: 32879-32890.
35. Jinks SL, Carstens E, Antognini JF, (2004). Isoflurane differentially modulates medullary on and off neurons while suppressing hind-limb motor withdrawals. Anesthesiology 100: 1224-1234.
36. Jordt SE, Bautista DM, Chuang HH, McKemy DD, Zygmunt PM, Högestätt ED, et al. (2004). Mustard oils and cannabinoids excite sensory nerve fibres through the TRP channel ANKTM1. Nature 427: 260-265.
37. Karst M, Wippermann S, (2009). Cannabinoids against pain. Efficacy and strategies to reduce psychoactivity: a clinical perspective. Expert Opin Investig Drugs 18: 125-133.
38. Kathuria S, Gaetani S, Fegley D, Valiño F, Duranti A, Tontini A, et al. (2003). Modulation of anxiety through blockade of anandamide hydrolysis. Nat Med 9: 76-81.
39. Kincaid W, Neubert MJ, Xu M, Kim CJ, Heinricher MM, (2006). Role for medullary pain facilitating neurons in secondary thermal hyperalgesia. J Neurophysiol 95: 33-41.
40. Kishimoto K, Koyama S, Akaike N, (2001). Synergistic mu-opioid and 5-HT1A presynaptic inhibition of GABA release in rat periaqueductal gray neurons. Neuropharmacology 41: 529-538.
41. Ligresti A, Schiano Moriello A, Starowicz K, Matias I, Pisanti S, De Petrocellis L, et al. (2006). Antitumor activity of plant cannabinoids with emphasis on the effect of cannabidiol on human breast carcinoma. J Pharmacol Exp Ther 318: 1375-1387.
42. Liou GI, Auchampach JA, Hillard CJ, Zhu G, Yousufzai B, Mian S, et al. (2008). Mediation of cannabidiol anti-inflammation in the retina by equilibrative nucleoside transporter and A2A adenosine receptor. Invest Ophthalmol Vis Sci 49: 5526-5531.
43. Magen I, Avraham Y, Ackerman Z, Vorobiev L, Mechoulam R, Berry EM, (2009). Cannabidiol ameliorates cognitive and motor impairments in mice with bile duct ligation. J Hepatol 51: 528-534.
44. Magen I, Avraham Y, Ackerman Z, Vorobiev L, Mechoulam R, Berry EM, (2010). Cannabidiol ameliorates cognitive and motor impairments in bile-duct ligated mice via 5-HT1A receptor activation. Br J Pharmacol 159: 950-957.
45. Maione S, Bisogno T, de Novellis V, Palazzo E, Cristino L, Valenti M, et al. (2006). Elevation of endocannabinoid levels in the ventrolateral periaqueductal grey through inhibition of fatty acid amide hydrolase affects descending nociceptive pathways via both cannabinoid receptor type 1 and transient receptor potential vanilloid type-1 receptors. J Pharmacol Exp Ther 316: 969-982.
46. Maione S, de Novellis V, Cappellacci L, Palazzo E, Vita D, Luongo L, et al. (2007). The antinociceptive effect of 2-chloro-2′-C-methyl-N6- cyclopentyladenosine (2′-Me-CCPA), a highly selective adenosine A1 receptor agonist, in the rat. Pain 131: 281-292.
47. Maione S, Morera E, Marabese I, Ligresti A, Luongo L, Ortar G, et al. (2008). Antinociceptive effects of tetrazole inhibitors of endocannabinoid inactivation: cannabinoid and non-cannabinoid receptor-mediated mechanisms. Br J Pharmacol 155: 775-782.
48. Maione S, Starowicz K, Cristino L, Guida F, Palazzo E, Luongo L, et al. (2009). Functional interaction between TRPV1 and micro-opioid receptors in the descending antinociceptive pathway activates glutamate transmission and induces analgesia. J Neurophysiol 101: 2411-2422.
49. Marsicano G, Wotjak CT, Azad SC, Bisogno T, Rammes G, Cascio MG, et al. (2002). The endogenous cannabinoid system controls extinction of aversive memories. Nature 418: 530-534.
50. Mechoulam R, Peters M, Murillo-Rodriguez E, Hanus LO, (2007). Cannabidiol-recent advances. Chem Biodivers 4: 1678-1692.
51. Meng ID, Manning BH, Martin WJ, Fields HL, (1998). An analgesia circuit activated by cannabinoids. Nature 395: 381-383.
52. Millan MJ, Członkowski A, Millan MH, Herz A, (1987). Activation of periaqueductal grey pools of beta-endorphin by analgetic electrical stimulation in freely moving rats. Brain Res 407: 199-203. (Pubitemid 17049849)
53. Moreau JL, Fields HL, (1986). Evidence for GABA involvement in midbrain control of medullary neurons that modulate nociceptive transmission. Brain Res 397: 37-46.
54. Neubert MJ, Kincaid W, Heinricher MM, (2004). Nociceptive facilitating neurons in the rostral ventromedial medulla. Pain 110: 158-165.
55. de Novellis V, Mariani L, Palazzo E, Vita D, Marabese I, Scafuro M, et al. (2005). Periaqueductal grey CB1 cannabinoid and metabotropic glutamate subtype 5 receptors modulate changes in rostral ventromedial medulla neuronal activities induced by subcutaneous formalin in the rat. Neuroscience 134: 269-281.
56. de Novellis V, Palazzo E, Rossi F, De Petrocellis L, Petrosino S, Guida F, et al. (2008). The analgesic effect of N-arachidonoyl-serotonin, a FAAH inhibitor and TRPV1 receptor antagonist, associated with changes in rostral ventromedial medulla and locus coeruleus cell activity in rats. Neuropharmacology 55: 1105-1113.
57. Ortar G, Ligresti A, De Petrocellis L, Morera E, Di Marzo V, (2003). Novel selective and metabolically stable inhibitors of anandamide cellular uptake. Biochem Pharmacol 65: 1473-1481.
58. Palazzo E, de Novellis V, Marabese I, Cuomo D, Rossi F, Berrino L, et al. (2002). Interaction between vanilloid and glutamate receptors in the central modulation of nociception. Eur J Pharmacol 439: 69-75.
59. Paxinos G, Watson C, (1986). The Rat Brain in Stereotaxic Coordinates. Academic Press: New York.
60. Petrosino S, Di Marzo V, (2010). FAAH and MAGL inhibitors: therapeutic opportunities from regulating endocannabinoid levels. Curr Opin Investig Drugs 11: 51-62.
61. Rahn EJ, Hohmann AG, (2009). Cannabinoids as pharmacotherapies for neuropathic pain: from the bench to the bedside. Neurotherapeutics 6: 713-737.
62. Rea K, Roche M, Finn DP, (2007). Supraspinal modulation of pain by cannabinoids: the role of GABA and glutamate. Br J Pharmacol 152: 633-648.
63. Resstel LB, Tavares RF, Lisboa SF, Joca SR, Corrêa FM, Guimarães FS, (2009). 5-HT1A receptors are involved in the cannabidiol-induced attenuation of behavioural and cardiovascular responses to acute restraint stress in rats. Br J Pharmacol 156: 181-188.
64. Russo EB, Burnett A, Hall B, Parker KK, (2005). Agonistic properties of cannabidiol at 5-HT1a receptors. Neurochem Res 30: 1037-1043.
65. Salas MM, Hargreaves KM, Akopian AN, (2009). TRPA1-mediated responses in trigeminal sensory neurons: interaction between TRPA1 and TRPV1. Eur J Neurosci 29: 1568-1578.
66. Sandkühler J, Gebhart GF, (1984). Relative contributions of the nucleus raphe magnus and adjacent medullary reticular formation to the inhibition by stimulation in the periaqueductal gray of a spinal nociceptive reflex in the pentobarbital-anesthetized rat. Brain Res 305: 77-87.
67. Starowicz K, Maione S, Cristino L, Palazzo E, Marabese I, Rossi F, et al. (2007). Tonic endovanilloid facilitation of glutamate release in brainstem descending antinociceptive pathways. J Neurosci 27: 13739-13749.
68. Sun B, Bang SI, Jin YH, (2009). Transient receptor potential A1 increase glutamate release on brain stem neurons. Neuroreport 20: 1002-1006.
69. Vaughan RP, Szewczyk MT Jr, Lanosa MJ, Desesa CR, Gianutsos G, Morris JB, (2006). Adenosine sensory transduction pathways contribute to activation of the sensory irritation response to inspired irritant vapors. Toxicol Sci 93: 411-421.
70. Watanabe K, Kayano Y, Matsunaga T, Yamamoto I, Yoshimura H, (1996). Inhibition of anandamide amidase activity in mouse brain microsomes by cannabinoids. Biol Pharm Bull 19: 1109-1111.
71. Wiertelak EP, Roemer B, Maier SF, Watkins LR, (1997). Comparison of the effects of nucleus tractus solitarius and ventral medial medulla lesions on illness-induced and subcutaneous formalin-induced hyperalgesias. Brain Res 748: 143-150.
72. Xu M, Kim CJ, Neubert MJ, Heinricher MM, (2007). NMDA receptor-mediated activation of medullary pro-nociceptive neurons is required for secondary thermal hyperalgesia. Pain 127: 253-262.
73. Zanelati TV, Biojone C, Moreira FA, Guimarães FS, Joca SR, (2010). Antidepressant-like effects of cannabidiol in mice: possible involvement of 5-HT1A receptors. Br J Pharmacol 159: 122-128.